Meet Our Scientific Advisory Board

Stanley Plotkin

Stanley Plotkin, M.D.


Stanley Plotkin, M.D., is a renowned vaccinologist who has played a pivotal role in the development of a rubella vaccine and co-developed many subsequent vaccines, including polio, rabies, varicella, rotavirus, and cytomegalovirus.  He is the founding author of the book, Vaccines, originally published in 1988, now in its seventh edition, which has become the authoritative textbook on the subject.  Dr. Plotkin was awarded an emeritus appointment at The Wistar Institute of Anatomy and Biology and the University of Pennsylvania.  Dr. Plotkin has served as chair of several committees, including the AAP’s Infectious Disease Committee.  One of his many career endeavors included serving as the Executive Advisor at Sanofi Pasteur. Dr. Plotkin attended New York University and obtained his medical degree from the State University of New York, Downstate Medical Center College of Medicine in Brooklyn. He completed his residency in pediatrics at Children’s Hospital of Philadelphia and the Hospital for Sick Children in London.

Margaret Liu, M.D.


Margaret Liu, M.D., has pioneered both bispecific antibody technology for cancer and DNA vaccines. Dr. Liu was the recipient of an NIH Physician-Scientist Award and has held appointments/adjunct appointments at the Massachusetts Institute of Technology, Harvard Medical School, the University of Pennsylvania, the Karolinska Institutet in Stockholm, and UCSF. She held leadership/executive positions at Merck Research Laboratories and Chiron Corporation, was Senior Advisor in Vaccinology at the Bill & Melinda Gates Foundation, Executive Vice-Chair of the International Vaccine Institute, and was on the US NIH NIAID Council. Dr. Liu obtained an M.D. from Harvard Medical School, a B.A. in Chemistry, summa cum laude, from Colorado College, and passed the Epreuve pour le Diplôme d’Enseignement, à l’unanimité (judges’ unanimous decision), in piano from the Ecole Normale de Musique de Paris.  She lectured at the invitation of the Nobel Committee and is the recipient of an honorary Doctor of Medicine from the Karolinska Institutet. She completed her clinical training at Massachusetts General Hospital/Harvard Medical School and received Board Certification in Internal Medicine and in Endocrinology and Metabolism.

Greg Poland

Greg Poland, M.D.

Greg Poland, M.D., is a physician, prominent infectious disease expert, and vaccinologist with a special focus on the immunogenetics of vaccine response.  Dr. Poland is the Editor-in-Chief of the prominent medical journal, Vaccine.  He is a Professor of Medicine and Infectious Disease at Mayo Clinic and the founder and Director of the Mayo Clinic Vaccine Research Group. In 2007, Dr. Poland was named to be president of the Health Defense Board and has been president of the Armed Forces Epidemiological Board and worked for over ten years as a consultant to the department.  In 2011 Dr. Poland received the MERIT award from the National Institutes of Health. He is a passionate, outspoken and effective advocate of vaccine use for global health.  Dr. Poland attended Southern Illinois University School of Medicine, followed by post-graduate work and a fellowship at the University of Minnesota/Abbott-Northwestern Hospital.

Phil Livingston

Phil Livingston, M.D.

Adjuvance Co-Founder

Dr. Phil Livingston helped to pioneer the immuno-oncology field, having worked as an oncologist and conducted research in cancer vaccinology and immunological adjuvants for more than 35 years until his retirement in 2011.  He was Professor of Medicine and Attending Physician in the Melanoma and Sarcoma Service, Department of Medicine at Memorial Sloan-Kettering Cancer Center (MSKCC). His research has led to the development of novel antibody-inducing cancer vaccines and synthetic immunological adjuvants, and he has published extensively on the subject.  Dr. Livingston is a graduate of Harvard Medical School and completed his medical residency in Internal Medicine in the North Shore-Memorial Hospital Cornell Cooperating Hospitals Program.